NEOGEN
Board
2 directors, 2 in day-to-day management, 1 auditor, last change in January 2026Cellular Consulting BO
Director
since 04-09-2025
term until 11-06-2031
listed in the 2025 annual accounts, filed on 27-10-2026
LMDC Advisory s.r.o.
Director and day-to-day manager, permanent representative Libor Matyásek
director since 01-01-2026
day-to-day manager appointed by deed of 16-01-2026
term until 11-06-2031, term without a fixed end
listed in the 2025 annual accounts, filed on 27-10-2026
Day-to-day manager, permanent representative Ivo Peeters
appointed by deed of 15-02-2021
term without a fixed end
also on the board of 10 other companies
Statutory auditor, permanent representative Pieter-Jan Van Durme
current term since 28-06-2024
term until 09-06-2027
listed in the 2025 annual accounts, filed on 27-10-2026
- LMDC Advisory s.r.o., HANDS-ON FINANCE SOLUTIONS
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Het mandaat van dagelijks bestuur van LMDC Advisory s.r.o., die zich hiervoor zal laten vertegenwoordigen door de heer Libor Matyásek, is…”deed of 16-01-2026
Permanent representatives 2
Ivo Peeters
Permanent representative, for HANDS-ON FINANCE SOLUTIONS
appointed by deed of 15-02-2021
Mandates through the years
10 names, the dashed line is todayCellular Consulting BO
Director
Director
LMDC Advisory s.r.o.
Director, Day-to-day manager
Director, Day-to-day manager
HANDS-ON FINANCE SOLUTIONS
Day-to-day manager
Day-to-day manager
DELOITTE Bedrijfsrevisoren BV
Statutory auditor
Statutory auditor
LMDC GmbH
Day-to-day manager
Day-to-day manager
Cellular Consulting LDA
Director
Director
Vilas Pharmaceutical Services ApS
Director
Director
Jacobsen Management
Director
Director
Alter Pharma NV
Director
Director
GRNR Invest BV
Director
Director
LeadershipBoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
- Cellular Consulting BO
- Director, from 01-01-2022 to date
- LMDC Advisory s.r.o.
- Director, since before 31-12-2025
- Day-to-day manager, appointed by deed of 16-01-2026, still in office
- HANDS-ON FINANCE SOLUTIONS
- Director, appointed by deed of 30-03-2020, until 30-07-2024
- Day-to-day manager, appointed by deed of 15-02-2021, until 01-07-2024
- Day-to-day manager, appointed by deed of 15-02-2021, still in office
- DELOITTE Bedrijfsrevisoren BV
- Statutory auditor, from 24-08-2021 to date
- LMDC GmbH
- Director, appointed by deed of 30-07-2024, until 31-12-2025
- Day-to-day manager, appointed by deed of 30-07-2024, until 31-12-2025
- Cellular Consulting LDA
- Director, from before 31-12-2021, no longer listed in the 2025 annual accounts
- Vilas Pharmaceutical Services ApS
- Director, appointed by deed of 30-03-2020, until 27-01-2022
- Jacobsen Management
- Director, appointed by deed of 30-03-2020, until 25-01-2021
- Alter Pharma NV
- Director, until 12-02-2020
- GRNR Invest BV
- Director, until 12-02-2020
Control
100%
This company
NEOGEN
Equity €14.1m
Profit €2.4m in 2025
Further up the chainA.forall Group 100%A forall Group NV consolidates
Capital
- Capital
- €7,335,797.80
- Shares
- 13,406
- Contribution per share
- €547
- Equity per share
- €1,050 in 2025
- Source
- deed of 23-07-2020
Owners through the years
as the annual accounts name themOwners as a list
- A.forall Group
- A.forall Development
Source: parent in its own accounts, lists of holdings in the owners' accounts
Articles of association
deed of 23-07-2020 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 3 directors“Raad van bestuur, raad kan voorzitter benoemen uit leden;bij ontstentenis of afwezigheid waarneming door bestuurder aangeduid onder…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Second Wednesday of June at 12:00
Shareholders
2 ownersOwners 2
- A.forall DevelopmentparentEquity €37.6m Loss of €1.7m in 2025 (profit of €12.3m in 2024)100%
- A forall Group NVconsolidating parentconsolidates
Capital transactions
Capital over time
- 23-07-2020 Capital increase of €2,080,600 · to €7,335,797.80 · 3,599 new shares, 26.8% of the 13,406 shares after the increase
- 26-05-2020 Capital stated in the deed · €5,255,197.80 · 9,807 shares